Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Atorvastatin Pre-Treatment Influences the Risk of Percutaneous Coronary Intervention Study 2

NCT01058057 is registered in ClinicalTrials.gov with University Hospital, Motol as lead sponsor.

NCT NCT01058057
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01058057 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Atorvastatin Pre-Treatment Influences the Risk of Percutaneous Coronary Intervention Study 2
Lead sponsor
University Hospital, Motol
Phase
Phase 3
Overall status
Unknown status
Start date
February 29, 2008
Completion date
Not reported
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary angioplasty, coronary artery disease